Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer

Anticancer Research

Volumn 19, Issue 5 C, 1999, Pages 4391-4393

  Moser, Patrizia L ^b   Kieback, Dirk G ^b   Hefler, Lukas ^b   Tempfer, Clemens ^b   Neunteufel, Walter ^b   Gitsch, Gerald ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

Cervical cancer; Immunohistochemistry; Metalloproteinases

Indexed keywords

COLLAGENASE; GELATINASE A; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UTERINE CERVICAL NEOPLASMS;

EID: 0033427522     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Burghardt E, Pickel H, Haas J and Lahousen M: Prognostic factors and operative treatment of stages IB to IIB cervical cancer. Am J Obset Gynecol 156: 988-996, 1987.
2. Noguchi H, Shiozawa I, Sakai Y, Yamazaki T and Fukuta T: Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol 27: 150-185, 1987.
3. Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyma T, Akazawa K and Nakano H: Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 69: 181-186, 1992.
4. Woessner FJ: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 75; 2145-2154, 1991.
5. Mignatti P and Rifkin D: Biology and biochemistry proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
6. Fishmany DA, Bafetti LM and Sharon Stack M: Membrane-Type Matrix. Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation in Primary Human Ovarian Epithelial Carcinoma Cells. Invasion Metastasis 16: 150-159, 1996.
7. Autio-Harmainen H, Karttunen T, Hurskainen T, Hoyhta M, Kauppila A and Tryggvason K: Expression of 72 kDa type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. ovarlall Lab Invest 69: 312-321, 1993.
8. Naylor MS, Stamp GW, Davies BD and Balkwill FR: Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer 58: 50-56 1994.
9. Afzalh S, Lalani EN, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M and Stamp GWH: Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Lab Invest 74: 406-421, 1996.
10. Davidson B, Goldberg I, Gotlieb WH, Ben-Baruch G, Kopolovic J: Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry. European Journal of Obstetrics & Gynecology and Reproductive Biology 76: 109-114, 1998.
11. Mignatti P, Rifkin DB: Biology and biochemistry proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
12. Dano K, Andrease PA, Grondahl-Hansen J, Kristensen P, Nielsen LS and Skriver L: Plasinogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139-166, 1985.
13. Sharon Stackt M, Ellerbroek SM, Fishman DA: The role of proteolytic enzymes in pathology of epithelial ovarian carcinoma (Review). International Journal of Oncology 12: 569-576, 1998.
14. Hawkins MJ: Clinical trials of antiangiogenetic agents. Curr-Opin Oncol 7: 90-3, 1995.
15. Obermair A, Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A, Leodolter S and Gitsch G: Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival. Am J Obstet Gynecol 178: 314-9, 1998.